Worcester health and human services commissioner to retire after 10 years
'I am retiring after 10 years. It's not easy for me to say those words because this work, and this city, have been my heart for a decade,' Castiel said in a press release from Batista's office. 'I have had the extraordinary privilege of serving a community I love alongside people who inspire me every single day. Together, we have faced enormous challenges and built bold, beautiful solutions. I have seen what's possible when compassion leads, when equity guides, and when justice is more than a goal but truly is a practice.'
Castiel immigrated from Cuba to the United States in 1962, according to the press release. For 36 years, she has worked as an internal medicine physician in Worcester, spending time at UMass Memorial Medical Center and Family Health Center of Worcester.
She is also an associate professor of internal medicine, family medicine and psychiatry at the UMass Chan Medical School.
In 2015, then City Manager Ed Augustus named Castiel to serve as the HHS commissioner.
Castiel's appointment came at a time when Worcester reconstituted its HHS department, which was previously eliminated in 2009 as part of budget cuts.
As HHS commissioner, Castiel helped establish the city's Housing First Coordinating Council, opioid task force and the mayor's mental health task force, the press release reads.
Recently, she worked with UMass Chan Medical School to create the Worcester Integrated Health Data Exchange — a partnership among health care agencies that provide Worcester health data to help better understand health inequities, trends, risk factors and outcomes, according to the press release.
'I want to congratulate Dr. Castiel on an incredibly impactful tenure as a public servant to the City of Worcester,' Batista said in the press release. 'Her dedication to this community has truly been inspiring – from her work to institute a syringe exchange program to launching a Housing First Coordinating Council to her leadership throughout the COVID-19 pandemic, running equity-based vaccination campaigns and shelters — she has proven herself as a compassionate problem solver and will leave a lasting legacy.'
With Castiel departing, Batista's administration will 'explore' options for the role of HHS commissioner and will relay its plan before Castiel's departure, according to the press release.
More Worcester Stories
New Jersey man charged with assault in Fitchburg fatal shooting
2-year-old in critical condition after falling from Worcester window
Disappointing jobs numbers mean 'this is Donald Trump's economy right now' say McGovern, Neal
Read the original article on MassLive.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TechCrunch
25 minutes ago
- TechCrunch
Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Linda Yaccarino's next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s. Yaccarino was a longtime advertising executive at NBCUniversal, but left to join X as CEO for two years, where she managed to have a positive impact on the social network's troubled ad revenue model, despite her and Elon Musk's shared approach to minimizing content moderation. Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her 'undeniable ability to negotiate new partnerships' — it certainly also helps that her tenure at X made her well-known in the tech world, drawing more eyes toward the startup. eMed previously produced a tech platform that was designed to be used with at-home COVID-19 rapid antigen tests, guiding users through the process of administering these tests properly. Now, eMed is focused on GLP-1s, the class of drugs like Ozempic, which can be used for both weight management and treatment of type II diabetes. 'To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry,' Yaccarino said in a press release. 'We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms.'
Yahoo
an hour ago
- Yahoo
From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health
Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services. Fellow Health provides clinical grade, mail-in analysis of male fertility and post-vasectomy status while committing to "privacy, convenience and timely results." Italready has a network of more than 2,500 fertility and urology providers nationwide and wants to "deepen its footprint" through expansion into employer-sponsored fertility benefits and "broader access initiatives." Don't Miss: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— led the latest funding round, in which asset management firm Forest Road participated for the first time. Forest Managing Partner of Life Sciences Bill Burkoth will join Fellow's board as part of the financing deal. Other investors since the initial round include Labcorp Venture Fund, Genoa Ventures and Mantis Venture Capital. "Fellow Health is exactly the kind of company we look for – operating in a large, overlooked market that's long overdue for disruption," Burkoth said in a statement. "With over 50,000 test results delivered so far this year, they've proven there is real demand for a better patient experience." Live sperm gets counted in fertility analysis. These cells can live three to days within the cervix, uterus and fallopian tubes, but usually die in under an hour outside a woman's body. The mail-in service addresses this time bomb with a "preservation solution designed to stabilize your sample and a gel pack that helps maintain a moderate temperature during transit." Mail-in post-vasectomy testing is less time critical because it counts both living and dead sperm. Trending: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Fellow Health points to studies backing up its claim that it can provide "results on par with traditional one-hour semen analysis when analyzing samples received within 52 hours of when they were produced." It sells both testing products and a cryopreservation service without a doctor's prescription at its website. 'Male reproductive health should not be reactive or inaccessible,' Fellow CEO Brian Hogan said in the statement. 'We are on track to deliver over 40% year-over-year revenue growth, with a path to profitability in our fertility segment by 2026. This investment allows us to scale that vision and support both patients and providers with modern tools that work.'However, Fellow Health faces stiff competition in the male fertility space that could impact this optimistic revenue outlook. Rival Posterity Health booked $13 million in Series A funding earlier this year. The company partnered with Mark Cuban Cost Plus Drug Company in 2023 to provide access to treatments for infertility, sexual dysfunction and low testosterone. A year earlier, American telehealth provider Ro bought Dadi, another male fertility and sperm testing startup. Its reproduction preservation service for men looks like a direct competitor to Fellow Health's family of products. Ro has also made a splash in women's health, acquiring Modern Fertility in 2021. Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Health care stocks were mixed Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Hea Sign in to access your portfolio
